Christopher M. Starr

Companies

• Monopar TherapeuticsBoard member Jan 8, 2018 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Monopar Therapeutics MNPR15,053 shares²$1.1M at $70.76Jul 16, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 14, 2025Sold 16,800 shares at $40.00 of Monopar Therapeutics²
• Jul 14, 2025Exercised 16,800 shares at $0.01 of Monopar Therapeutics²
• Dec 31, 2023Exercised options 2,533 shares of Monopar Therapeutics³
• Sep 30, 2023Exercised options 2,533 shares of Monopar Therapeutics⁴
• Jun 30, 2023Exercised options 2,534 shares of Monopar Therapeutics⁵
• Mar 31, 2023Exercised options 2,533 shares of Monopar Therapeutics⁶
• Dec 31, 2022Exercised options 2,859 shares of Monopar Therapeutics⁷
• Sep 30, 2022Exercised options 2,859 shares of Monopar Therapeutics⁸
• Jun 30, 2022Exercised options 2,859 shares of Monopar Therapeutics⁹
• Mar 31, 2022Exercised options 2,859 shares of Monopar Therapeutics¹⁰
• Dec 31, 2021Exercised options 751 shares of Monopar Therapeutics¹¹
• Sep 30, 2021Exercised options 751 shares of Monopar Therapeutics¹²